FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:616-617 March 2, 1995 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

(Infectious Disease and Therapy. Vol. 12.) Edited by Aldona L. Baltch and Raymond P. Smith. 615 pp. New York, Marcel Dekker, 1994. $195. ISBN 0-8247-9210-6.

Pseudomonas aeruginosa is a paradigm of the opportunistic pathogen. Over the first four decades of the antimicrobial era, this organism transformed itself from an uncommon and unremarkable pathogen to one of the principal agents of nosocomial infections that cause morbidity and mortality in hospitalized patients. In response to this change, extensive molecular, biologic, clinical, and therapeutic research has been directed toward gaining a better understanding of P. aeruginosa infections. In the past several years, however, P. aeruginosa has been eclipsed by gram-positive organisms as a cause of nosocomial infection and by antimicrobial resistance as a therapeutic problem.

This period . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.